Fundz

Coherence Neuro raises $45M in Series A funding, co-led by Founders Fund and the OpenAI Startup Fund. The funds will be used to advance clinical trials and expand research into pancreatic cancer.

PRIVATEOct 22, 2026

Amount Raised

$45 Million

Round Type

Series A

San FranciscoBiotechnologyHealth CareArtificial IntelligenceMedicalMedical DeviceHealth Diagnostics

Investors

Dr. Rory MurphyDr. Matthew MacDougallMaor ShlomoChad ByersRomina NejadDivergentXtalXeiaArtesianTopologyPossibleBlackbirdAhrenOlive CapitalTimeless8VCLux CapitalOpenAI Startup FundFounders Fund

Description

Coherence Neuro, a San Francisco-based developer of AI-powered oncology medical devices, raised $45M in Series A funding. The round was co-led by Founders Fund and the OpenAI Startup Fund, with participation from various new and existing investors. The capital will help advance their first chronic human clinical trial in glioblastoma and expand their research initiatives. The company specializes in implantable devices that monitor and treat cancer using AI.

Who to call at Coherence Neuro, and when

A new round usually means Coherence Neuro is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Coherence Neuro raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Coherence Neuro, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Coherence Neuro

Location

San Francisco, California, United States

About

Coherence Neuro is a developer of AI-powered oncology medical devices. The company focuses on creating specialized implantable or wearable bioelectronic devices that monitor and treat cancer by analyzing live human biological data. Their efforts aim to advance chronic human clinical trials and seek FDA breakthrough device designation. Coherence Neuro is led by CEO Ben Woodington and CTO Dr. Elise Jenkins.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Coherence Neuro raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Coherence Neuro's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Coherence Neuro raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.